|
J Biol Chem, Vol. 273, Issue 33, 21225-21231, August 14, 1998
Involvement of a Lysine-specific Cysteine Proteinase in
Hemoglobin Adsorption and Heme Accumulation by Porphyromonas
gingivalis*
Kuniaki
Okamoto §,
Koji
Nakayama¶,
Tomoko
Kadowaki §,
Naoko
Abe ,
Dinath B.
Ratnayake¶, and
Kenji
Yamamoto
From the Departments of Pharmacology and
¶ Microbiology, Kyushu University Faculty of Dentistry,
Higashi-ku, Fukuoka 812-8582, Japan
 |
ABSTRACT |
The oral anaerobic bacterium Porphyromonas
gingivalis, a major pathogen of advanced adult periodontitis,
produces a novel class of cysteine proteinases in both cell-associated
and secretory forms. A lysine-specific cysteine proteinase
(Lys-gingipain, KGP), as well as an arginine-specific cysteine
proteinase (Arg-gingipain), is a major trypsin-like proteinase of the
organism. Recent studies indicate that the secreted KGP is implicated
in the destruction of periodontal tissue and the disruption of host
defense mechanisms. In this study, we have constructed a KGP-deficient
mutant to determine whether the cell-associated KGP is important for
pathophysiology of the organism. Although the mutant retained the
strong ability to disrupt the bactericidal activity of
polymorphonuclear leukocytes, its hemagglutination activity was reduced
to about one-half that observed with the wild-type strain. More
important, the mutant did not form black-pigmented colonies on blood
agar plates, indicating the defect of hemoglobin adsorption and heme
accumulation. Immunoblot analysis showed that the expression of a
19-kDa hemoglobin receptor protein, which is thought to be responsible
for hemoglobin binding by the organism, was greatly retarded in this
mutant. The mutant also showed a marked decrease in the ability to
degrade fibrinogen. These results suggest the possible involvement of
KGP in the hemoglobin binding and heme accumulation of the organism and
in the bleeding tendency in periodontal pockets.
 |
INTRODUCTION |
The proteinases of the Gram-negative, black-pigmented anaerobe
Porphyromonas gingivalis are believed to be involved in a
wide range of pathologies of progressive periodontal disease (reviewed in Refs. 1 and 2). Recently, the trypsin-like activity associated with
the organism is found to be attributable to either Arg-X- or
Lys-X-specific cysteine proteinase (where X is an
unknown amino acid residue) (3). These two enzymes have now been termed
Arg-gingipain (gingipain-R,
RGP)1 and Lys-gingipain
(gingipain-K, KGP) on the basis of their peptide cleavage specificity
after arginine and lysine residues, respectively. Catalytic and
structural studies have revealed that these enzymes are a novel class
of the cysteine proteinase family (1).
Recently, it has been suggested that the proteolytic activities of RGP
and KGP are involved in the pathogenesis of progressive periodontal
disease through the following mechanisms: (i) directly degrading
structural proteins of the periodontal tissues (4-12), (ii) disrupting
host defense mechanisms (7, 13-19), (iii) activating or stimulating
the expression of hemagglutinins (20), (iv) processing and
translocating adhesion molecules (21), and (v) inducing or stimulating
inflammation through the production of chemical mediators (10, 22, 23).
Previous studies of RGP-deficient mutants constructed by use of suicide
plasmid systems revealed that RGP plays a major role in the disruption
of polymorphonuclear leukocyte (PMN) functions and the hemagglutination
and fimbriation by the organism (20, 21). However, little information
is available about to what extent KGP contributes to the entire
virulence of P. gingivalis. To gain some insight into this
question, it is necessary to undertake the molecular genetic
approach.
So far, three genes encoding Lys-X-specific cysteine proteinases have
been cloned and sequenced, but all of the genes seem to be essentially
equivalent to one another (24-26). Southern hybridization analyses
have also suggested that a single KGP-encoding gene exists on the
chromosome of P. gingivalis (24). The nucleotide sequence of
the kgp gene of P. gingivalis strain and the
deduced amino acid sequence have suggested that the precursor of KGP
comprises at least four domains: the signal peptide, the amino-terminal propeptide, the catalytic proteinase domain, and the carboxyl-terminal hemagglutinin domain. In the present study, we have constructed a
KGP-deficient mutant via disruption of the kgp gene by use
of suicide plasmid systems to analyze the function of KGP in the organism. The results provide evidence suggesting that KGP is associated with hemagglutination, hemoglobin binding and heme accumulation by the organism, and the bleeding tendency in periodontal pockets and that it is not directly implicated in the production of
virulence factors responsible for suppression of the bactericidal activity of PMNs.
 |
EXPERIMENTAL PROCEDURES |
Media and Conditions for Cell Growth--
P.
gingivalis cells were grown anaerobically (10% CO2,
10% H2, 80% N2) in enriched BHI broth
(containing, per liter, 37 g of brain heart infusion (Difco),
5 g of yeast extract (Difco), 1 g of cysteine, 5 mg of hemin,
and 1 mg of vitamin K1) and on enriched BHI agar
(containing, per liter, 15 g of agar (Nakarai, Tokyo, Japan),
37 g of brain heat infusion, 5 g of yeast extract, 1 g
of cysteine, 5 mg of hemin, and 1 mg of vitamin K1). L
broth (containing, per liter, 10 g of tryptone (Difco), 5 g
of yeast extract, and 5 g of sodium chloride) was used for growing
Escherichia coli cells. For selection or maintenance of the
antibiotic-resistant strains, antibiotics were added to the medium at
the following concentrations: ampicilin, 200 µg/ml; erythromycin, 10 µg/ml.
DNA Manipulation--
Chromosomal DNA was isolated from P. gingivalis cells by the guanidine isothiocyanate method (27) with
the IsoQuick DNA extraction kit (MicroProbe, Garden Grove, CA) for
Southern blot analyses.
Plasmid Construction--
Suicide plasmids constructed in this
study are depicted in Fig. 1. An
~3.5-kbp BamHI fragment of plasmid pNKV (24), containing the gene of whole KGP proteinase domain, was ligated to pUC118, which
was digested with EcoRI, filled in by the Klenow enzyme, digested with BamHI, and treated with alkaline phosphatase.
The resulting plasmid was then digested with EcoRI and
self-ligated to make a deletion within the kgp gene, giving
rise to plasmid pNKV-2. A BamHI chromosomal fragment (3.3 kbp) of pNKV-2 was then ligated to pKD283 DNA (28) that had been
linearized with BamHI and treated with alkaline phosphatase,
resulting in plasmid pNKD.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 1.
Plasmid construction. Amp,
ampicilin resistance; Em, erythromycin resistance;
GUS, -glucuronidase gene; ori, replication
origin functioning in E. coli;
f1( )1G, f1( ) intergenic region;
lacZ, -galactosidase gene; ColE1 ori,
replication origin. The black region is a partial
kgp gene (signal sequence, amino-terminal prodomain,
proteinase domain, and a part of carboxyl-terminal prodomain).
Restriction sites: B, BamHI; H,
HindIII; RI, EcoRI; RV,
EcoRV.
|
|
DNA Probes and Southern Blot Hybridization--
Two synthetic
oligonucleotides, 5'-GCTAGTGCTGCTCCGGTCTTCTTGG-3' (Probe I) and
5'-GCGAGGACTACTATTGGAGTGTCGG-3' (probe II), were obtained from Greiner
Japan (Tokyo, Japan) and Kurabo (Osaka, Japan), respectively, and were
labeled with fluorescein-dUTP (Amersham Pharmacia Biotech, Little
Chalfont, UK). Chromosomal DNA of wild-type and KGP-deficient strains
was digested with HindIII and subjected to a 0.8% agarose
gel for Southern blot analysis. Digested genome DNA was transferred to
a nitrocellulose membrane (Schleicher & Schuell) essentially according
to Southern (29). Hybridization with probes I and II and detection of
signals were done by using the ECL 3'-oligolabeling (Amersham) and the
SuperSignalTM Nucleic Acid (Pierce), respectively.
Electrotransformation of P. gingivalis with pNKD Plasmid
DNA--
P. gingivalis cells were anaerobically grown to
6 × 108/ml at 37 °C in enriched BHI broth. The
cells were then harvested by centrifugation, washed with the
electroporation solution (300 mM sucrose), and resuspended
in 0.1 volume of the same solution. 10 µl of pNKD plasmid DNA
solution (300 µg of DNA/ml in TE buffer) were added to 0.4 ml of the
cell suspension. The whole volume of the DNA-containing cell suspension
was poured into a cuvette for electroporation (PulserTM
cuvette with 0.2-cm electrode gap, Bio-Rad). Electroporation was
performed at 2.0 kV with an electroporation apparatus (Gene PulserTM, Bio-Rad). These procedures were carried out at
4 °C. The cell suspension was immediately mixed with 10 ml of
prewarmed enriched BHI broth and incubated anaerobically at 37 °C
for 15 h. Cells of the culture were spread on enriched tryptic soy
agar containing erythromycin and incubated anaerobically at 37 °C
for 7 days.
Preparation of Culture Supernatants and Cell
Extracts--
24-hour cultures were harvested by centrifugation at
10,000 × g for 30 min at 4 °C. Ammonium sulfate was
added to the culture supernatant to a final concentration of 75%
saturation. The precipitated proteins were collected by centrifugation
at 10,000 × g for 20 min and suspended in 10 mM sodium phosphate buffer (pH 7.0) containing 0.05% Brij
35. After overnight dialysis against the same buffer at 4 °C,
insoluble materials were removed by centrifugation at 25,000 × g for 30 min. The resulting supernatant was used as a culture supernatant in this study. On the other hand, bacterial cells
were washed with phosphate-buffered saline (PBS) and resuspended in 10 mM sodium phosphate buffer (pH 7.0) containing 0.05% Brij 35. Cell extracts were prepared by ultrasonication followed by centrifugation at 25,000 × g for 30 min.
Gel Electrophoresis and Immunoblot
Analysis--
SDS-polyacrylamide gel electrophoresis was performed
according to the method of Laemmli (30). The proteinase inhibitor
leupeptin was added to a solubilizing buffer to avoid proteolysis by
endogenous proteinases. For immunoblotting, proteins on SDS gels were
electrophoretically transferred to nitrocellulose membranes according
to the method of Towbin et al. (31). The blotted membranes
were immunostained with the antibodies immunoreacting both RGP and KGP
(20) or the antibodies specific for the 19-kDa hemoglobin receptor
protein purified essentially according to the procedure described
previously (32).
Enzymatic Assay--
Lys-X- and Arg-X-specific cysteine
proteinase activities were determined by use of the synthetic
substrates t-butyloxycarbonyl-Val-Leu-Lys-MCA and
carbobenzoxy-Phe-Arg-MCA, respectively, as described previously (7,
33). Briefly, the reaction mixture (1 ml) contained various amounts of
the cell extracts or the culture supernatants, 10 µM each
synthetic substrate, and 5 mM cysteine in 20 mM
sodium phosphate buffer (pH 7.5). After incubation at 40 °C for 10 min, the reaction was terminated by adding 1 ml of 10 mM
iosoacetic acid (pH 5.0), and the released 7-amino-4-metylcoumarin was
measured at 460 nm (excitation at 380 nm) on a fluorescence
spectrophotometer.
Degradation of Fibrinogen--
The cell-free culture
supernatants of the P. gingivalis strains were obtained by
centrifugation at 10,000 × g for 20 min at 4 °C.
Ammonium sulfate was added to the culture supernatant to give 75%
saturation. The precipitated proteins were collected by centrifugation
at 10,000 × g for 20 min and resuspend in 10 mM sodium phosphate buffer (pH 7.0) containing 0.05% Brij
35. After dialysis against the same buffer at 4 °C overnight,
insoluble materials were removed by centrifugation at 25,000 × g for 30 min. 20 µg of human fibrinogen were incubated
with the respective dialysates (1 µg) for 4 h at 37 °C, and
then electrophoresis was performed on SDS gels. The gel was stained
with Coomassie Brilliant Blue R-250. Five points of each band were
measured and averaged by Microcomputer Imaging Device.
Determination of Hemoglobin Adsorption of P. gingivalis
Cells--
Hemoglobin adsorption was determined essentially according
to Fujimura et al. (34). Briefly, P. gingivalis
cells were grown anaerobically in enriched BHI broth overnight. The
cells were harvested from 1 ml of the culture, washed with 50 mM acetate buffer (pH 6.0), and resuspended in the original
volume of the same buffer. Cell density of the suspension was then
adjusted to an optical density (650 nm) of 0.73. The cell suspension
(730 µl) was mixed with 270 µl of human hemoglobin (1 mg/ml in the same buffer). The mixture was incubated at 37 °C for 30 or 60 min
and centrifuged at 10,000 × g for 15 min. The
absorbance of the supernatant was then measured at 410 nm. Adsorbed
hemoglobin was evaluated by decrease of absorbance of the
supernatant.
Measurement of Luminol-dependent CL Response--
CL
response of PMNs was measured according to the method described
previously (7).
Hemagglutination Assay--
Overnight cultures of P. gingivalis strains were centrifuged, washed twice with PBS, and
resuspended in PBS at an optimal density at 660 nm of 0.44. The
bacterial suspensions were then diluted in a 2-fold series with PBS. A
100-µl aliquot each of the dilutions was mixed with an equal volume
of sheep erythrocyte suspension (2.5% in PBS) and incubated in a
round-bottom microtiter plate at room temperature for 3 h.
 |
RESULTS |
Construction of a KGP-deficient Mutant and Southern Blot
Analyses--
A KGP-deficient mutant was constructed via gene
disruption by use of a suicide plasmid containing a part of the
kgp gene. The suicide plasmid pNKD contained an
amino-terminal region of the kgp gene lacking a 132-bp
EcoRI region within the gene. Emr transformants
were obtained after introduction of pNKD plasmid DNA into P. gingivalis ATCC33277 by electroporation (Fig.
2A). Four possible chromosomal
structures may arise from integration of the plasmid DNA: single
cross-over types (a and b) and apparent gene conversion types (c and d)
(Fig. 2A). Types a and b could be accounted for by
reciprocal recombination between homologous DNA regions of the
chromosome and the plasmid, whereas types c and d would be generated by
multiple reciprocal recombination or nonreciprocal recombination (gene
conversion) (35, 36). Southern analyses revealed that we only obtained
two types of Emr transformants: one (type c) with the
intact kgp gene (KDM16) and the other (type d) with a
deletion in kgp (KDM35), whereas Emr
transformants of types a and b could not be obtained. Thus, Southern hybridization analysis of their chromosomes was carried out with two
synthetic oligonucleotides to determine which types of transformants were produced. Probe I was a 25-bp oligonucleotide hybridizing to one
region of the KGP proteinase domain, whereas probe II was a 25-bp
oligonucleotide hybridizing a region within the 132-bp EcoRI
region. The chromosomal DNA of the Emr transformants of
types a and b has two HindIII DNA fragments (1.2 and 1 kbp)
hybridizing to probe I and II. The chromosomal DNA of c-type
transformants has one HindIII fragment (1.2 kbp) hybridizing
to probe I and II, whereas that of d-type transformants has one
HindIII fragment (1 kbp) hybridizing to probe I and no DNA
fragment hybridizing to probe II. The chromosomal DNA of the wild-type
parent has one HindIII fragment (1.2 kbp) hybridizing to
probes I and II. Southern analysis using probes I and II revealed that
KDM16 and KDM35 were of types c and d, respectively (Fig. 2B).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 2.
Chromosomal structures around the kgp
regions of the Emr transformants (A) and
Southern blot analysis of their chromosomal DNA (B).
A, DNA regions complementary to the kgp-specific
oligonucleotides that were used as DNA probes for Southern blot
analysis were indicated under the physical map of the chromosomal DNA
of the wild-type strain. Four possible structures arise from plasmid
integration by a single cross-over (a and b) and gene conversion (c and
d). The white boxes indicate the EcoRI segment of
the kgp gene. Arrowheads show a deletion of the
segment. Restriction sites: B, BamHI;
H, HindIII; RI, EcoRI;
RV, EcoRV. Emr, erythromycin
resistance. B, chromosomal DNAs of the wild-type strain and
KGP-mutants were digested with HindIII and subjected to a
0.8% agarose gel for Southern blot analysis. Probe I,
5'-GCTAGTGCTGCTCCGGTCTTCTTGG-3', and probe II,
5'-GCGAGGACTACTATTGGAGTGTCGG-3'. Lanes 1, the wild-type
ATCC33277; lanes 2, KDM16; lanes 3, KDM35.
|
|
Western Blot Analysis with Antibodies Recognizing Both KGP and RGP
and the KGP Activity--
To determine whether the transformant KDM35
was devoid of KGP protein, immunoblot analysis of the mutant was
performed by use of antibodies reacting with both KGP and RGP (Fig.
3). The culture supernatant of ATCC33277
(wild-type parent) showed four clear protein bands with apparent
molecular masses of 51, 44, 40 and 32 kDa and a smearing band of
70-100 kDa. There was no significant difference in electrophoretic
profiles between KDM16 and ATCC33277, although the 40- and 32-kDa
proteins were markedly decreased in KDM16. The 32-kDa protein was also
detected in KDM35. However, both the cell extract and culture
supernatant of KDM35 was devoid of the 51-kDa band. The 40-kDa protein
could be detected by immunoblotting of a large amount of the
supernatant proteins of KDM35, whereas the 51-kDa protein was not
observed under the same conditions (data not shown). Therefore, the
51-kDa protein appeared to be KGP. On the other hand, the proteins of
44, 40, 32, and 70-100 kDa seemed to be derived from the
rgp gene products, although its expression level was
slightly different between the wild-type parent and its mutants, which
was consistent with a previous study (20).

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 3.
Immunoblot analyses of cell extracts and
culture supernatants of the kgp mutant with antibodies
recognizing RGP and KGP. Both cell extracts (lanes
1-3) and culture supernatants (lanes 4-6) from
ATCC33277, KDM16, and KDM35 (each 20 µg of protein) were subjected to
SDS-polyacrylamide gel electrophoresis on 10% gel. Proteins separated
on the gels were transferred to nitrocellulose membranes and
immunostained with antibodies recognizing both RGP and KGP. Lanes
1 and 4, ATCC33277; lanes 2 and
5, KDM16; lanes 3 and 6, KDM35. The
51-kDa protein of the ATCC33277 that is lacking in KDM35 is indicated
by closed circles.
|
|
KGP can specifically cleave the Lys-X peptide bond. The proteolytic
activity on the synthetic substrate
t-butyloxycarbonyl-Val-Leu-Lys-MCA was scarcely detectable
in either the cell extract or the culture supernatant of KDM35, whereas
KDM16 showed the same activity in these fractions as the parent
ATCC33277 (Fig. 4A). On the
other hand, the hydrolyzing activity on the synthetic substrate
carbobenzoxy-Phe-Arg-MCA, which represents the RGP activity, was not
significantly changed in either fraction of KDM35, as well as KDM16
(Fig. 4B). Thus, KDM35 was found to be devoid of KGP at the
protein and activity levels, indicating that KDM35 is a KGP-deficient
mutant that possesses a deletion within the proteinase domain region of
the kgp gene.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 4.
Proteolytic activities of the KGP-deficient
mutant. Lys-X-specific (A) and Arg-X-specific cysteine
proteinase activities (B) in the cell extracts and culture
supernatants of ATCC33277 (WT), KDM16 (16), and
KDM35 (35) were assayed with
t-butyloxycarbonyl-Val-Leu-Lys-MCA and
carbobenzoxy-Phe-Arg-MCA, respectively. Each point is the mean ± S.D. of three experiments. **, p < 0.01 for
differences from the wild-type ATCC33277.
|
|
Effect on CL Response of PMNs--
The culture supernatant of the
wild-type strain contained potent virulence factors, which disrupt the
bactericidal function of PMNs (37). Both RGP and KGP purified from the
culture supernatant of P. gingivalis exhibited the potent
suppressive activity against the CL response of PMNs stimulated by
serum-activated zymosan (7, 33). Further, in agreement with the
previous results (20), the culture supernatant of the RGP-null mutant
(the rgpA rgpB double mutant, KDP112) was shown to almost
completely lose the inhibitory effect on the CL response of PMNs,
confirming that RGP is responsible for suppression of the bactericidal
function of PMNs (Fig. 5A). In
contrast, the culture supernatant of the KGP-deficient mutant (KDM35),
like the wild-type strain and KDM16, resulted in the intense inhibition
of the CL response of PMNs, suggesting that contribution of KGP to the
inhibition of the bactericidal activity of PMNs by the culture
supernatant of P. gingivalis is not as much as that of RGP
and that KGP is not directly involved in the production of P. gingivalis factors responsible for the inhibition.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 5.
Suppressive activity on the bactericidal
activity of PMNs (A) and hemagglutinating activity
(B) of the kgp mutant. A,
guinea pig PMNs (1 × 107 cells/ml) were preincubated
with the culture supernatants of ATCC33277, KDM16, KDM35, and KDP112
(50 mg of protein each) at 37 °C for 30 min. Then, PMNs were washed
and resuspended in PBS at a final concentration of 2 × 107 cells/ml). The CL response of the PMNs was measured
after stimulating by opsonized zymosan. The values are expressed as
percentages of that obtained with PBS. Each point is the mean ± S.D. of two experiments. B, the hemagglutinin titers of
ATCC33277, KDM16, KDM35, and KDP112 were determined as the last
dilution exhibiting full agglutination. The values were expressed as
percentages of that obtained with the wild-type strain ATCC33277.
|
|
Hemagglutination--
In our previous study (20), we found that
the RGP-null mutant showed a greater decrease in the hemagglutinating
activity observed with the wild-type strain. Because the initial
translation product of KGP appeared to contain the hemagglutinin domain
in the carboxyl-terminal region (24), which is significantly homologous to that of the RGP gene product (38), it is of special importance to
determine whether KGP is related to hemagglutination of P. gingivalis. The RGP-null mutant almost completely lost the intense hemagglutinating activity observed with the wild-type strain. Although
KDM16 had the same hemagglutinating activity as the wild-type strain,
KDM35 reduced the extent of hemagglutination to one-half those of the
wild-type strain and KDM16 (Fig. 5B). These results indicate
a significant contribution of the cell-associated KGP to the
hemagglutination of P. gingivalis.
Black Pigmentation--
As shown in Fig.
6, P. gingivalis strains
produce black-pigmented colonies on laked blood agar plates. It is
generally accepted that the black pigments are heme, which is an
absolute requirement for growth of P. gingivalis (39, 40),
and that it is probably derived from erythrocytes in the natural niche
for the organism. Therefore, it is particularly important for the
organism to aggregate and lyse erythrocytes to survive in
vivo (41, 42). To determine whether KGP is involved in the
formation of black-pigmented colonies, KDM35 was grown on laked sheep
blood agar. Although KDM16, like the wild-type strain, developed
black-pigmented colonies, KDM35 formed less pigmented colonies (Fig.
6). Further, it is questionable whether KDM35, the RGP-null mutant, and
the wild-type strain can form black-pigmented colonies when grown on
enriched tryptic soy agar plates with or without 2% hemoglobin (data
not shown). On the plate without hemoglobin, neither of them showed
both cell growth and black pigmentation. However, in the presence of
hemin in enriched tryptic soy agar plates each strain resulted in the cell growth but not black pigmentation. In the presence of hemoglobin, only KDM35 did not form black-pigmented colonies, but it retained the
cell growth activity. These findings indicate that KGP seems to be
involved in the hemoglobin adsorption and the heme accumulation by the
organism.

View larger version (109K):
[in this window]
[in a new window]
|
Fig. 6.
Clonial pigmentation. P. gingivalis strains (ATCC33277, KDM16, and KDM35) were inoculated
on the laked sheep blood agar plate and incubated anaerobically at
37 °C for 7 days.
|
|
Hemoglobin Adsorption and Hemoglobin Receptor Protein
Production--
More recent work in our laboratory has resulted in the
identification and purification of a prominent 19-kDa protein that was
significantly expressed in P. gingivalis when grown on blood agar plate (32). This protein was found to be the hemoglobin receptor
(HbR) protein (34) that was intragenically encoded by the
rgp1, kgp, and hagA genes of P. gingivalis (24, 43, 44). Also, it was interesting to note that HbR
protein was not expressed in nonpigmented mutants (BE1 and BR1) that
were isolated from the W50 strain of P. gingivalis (45) and
that the ability of these mutants to bind hemoglobin was markedly
decreased (34). Therefore, to determine whether the decreased
pigmentation of KDM35 is attributable to a defect of hemoglobin
adsorption, we examined the mutant for the ability to bind hemoglobin.
The results indicate that KDM35 binds hemoglobin to a lesser extent
than the kgp+ sibling strain KDM16 (Fig.
7A). Immunoblot analysis with
anti-HbR antiserum revealed that the cell extract of KDM35 grown on the laked blood agar for 3 days produced no HbR protein, whereas that of
KDM16 produced a single protein band with an apparent molecular mass of
19 kDa (Fig. 7B). However, after 7 days of incubation KDM35
produced a small amount of the HbR protein, and after 17 days it
produced as much as that of KDM16.

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 7.
Analyses of the hemoglobin adsorption and HbR
protein expression in the KGP-deficient mutant. A, the
cell suspensions of kgp+ sibling strain (KDM16)
and KGP-deficient mutant (KDM35) were incubated with human hemoglobin
at pH 6.0 and 37 °C for 30 or 60 min and centrifuged. Hemoglobin
adsorption was evaluated by decrease in the absorbance of supernatants
at 410 nm. Closed and open circles indicate KDM35
and KDM16, respectively. Bars represent the means ± S.D. of three experiments. B, the cell extracts of KDM16 and
KDM35 were separated by SDS-polyacrylamide gel electrophoresis and
subjected to immunoblot analysis with antiserum to HbR.
|
|
Degradation of Fibrinogen--
Fibrinogen is a 300-kDa protein
that consists of three pairs of polypeptide chains (designated A ,
B , and ) covalently linked by disulfide bonds. Thrombin is known
to convert fibrinogen to fibrin monomers, leading to forming of a
fibrin gel. Because of the bleeding tendency in periodontal pockets and
the observation that P. gingivalis gingipains cleave
fibrinogen (46-48), we examined whether KGP contributes to blocking
blood coagulation in the periodontal pockets. For this, the culture
supernatants freshly harvested from KDM35, KDP112, and the wild-type
strain were incubated with human fibrinogen at 37 °C for 4 h
(Fig. 8A). All of the chains were extensively degraded by the culture supernatants of the wild-type strain and the RGP-null mutant, although the former was more effective than the latter. However, the culture supernatant of the KGP-deficient mutant KDM35 was less effective in proteolysis of these chains, especially B and chains. Densitometric scanning revealed that the degradation by the culture supernatant of KDM35 was reduced to
about one-half that of the wild-type strain for the A and B
chains and one-fourth that of the wild-type strain for the chain
(Fig. 8B).

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 8.
Degradation of human fibrinogen by the
culture supernatants of the RGP-deficient and KGP-deficient
mutants. A, human fibrinogen (20 µg) was
incubated with the culture supernatants of the wild-type parent
(ATCC33277), the RGP-null mutant (KDP112), and the KGP-null mutant
(KDM35) (1 µg of protein each) for 4 h at 37 °C and then
analyzed by SDS-polyacrylamide gel electrophoresis (10% polyacrylamide
gel) under reducing conditions. The gel was stained with Coomassie
Brilliant Blue R-250. Lane 1, 20 µg of fibrinogen;
lane 2, ATCC33277; lane 3, KDP112; lane
4, KDM35. Numbers on the left indicate
relative molecular masses (kDa) of standard proteins. Arrows
indicate protein bands corresponding to the A , B , and chains
of fibrinogen. B, each chain of fibrinogen was quantitated
by scanning densitometry, and the integrated optical densities were
converted to a relative protein value expressed as a percentage
relative to the value observed with fibrinogen as a standard.
White bars, fibrinogen; hatched bars, ATCC33277;
black bars, KDP112; gray bars, KDM35. Each point
is the mean ± S.D. of five experiments.
|
|
 |
DISCUSSION |
In our previous study (20), we constructed RGP-deficient mutants
from P. gingivalis ATCC33277 and provided evidence
suggesting that RGP plays critical roles in inhibition of the
bactericidal activity of PMNs and the hemagglutination by the organism.
In this study, we have constructed the KGP-deficient mutant, designated KDM35, from P. gingivalis ATCC33277 by integration of the
Emr suicide plasmid pNKD containing a DNA fragment of the
gene to clarify the KGP function in the organism. The cell extract and culture medium of KDM35 showed no Lys-X-specific cysteine proteinase activity but still retained the same Arg-X-specific cysteine proteinase activity as that of the wild-type strain in both fractions, indicating that only the KGP proteinase gene is disrupted.
We have previously shown that the initial translation product of KGP,
like RGP, contains the hemagglutinin-related sequence in the
carboxyl-terminal domain (24) and that the RGP-null mutant KDP112 is
almost devoid of the hemagglutinating activity and loses the inhibitory
effect on the bactericidal activity of PMNs (20). More recently, we
have also found that the purified KGP significantly inhibits the
bactericidal activity of PMNs (37). Therefore, in this study we
determined to what extent KGP contributes to the disruption of host
defense mechanisms and the hemagglutinating activity by P. gingivalis by biochemical analysis of the KGP-deficient mutant
KDM35. Morphologically, KDM35 possessed a similar number of
characteristic kinky fimbriae on the cell surface of the wild-type strain. Taken together, the precursors of fimbrilin, a major component of fimbriae, and a 75-kDa cell surface protein have been shown to
undergo normal processing in
KDM35.2 These results suggest
that KGP is not significantly involved in processing and translocation
of the cell surface proteins. The culture supernatant of this mutant
also had the same suppressive activity on the CL response of PMNs as
that of the wild-type strain, indicating that KGP has little
contribution to production of virulence factor(s) responsible for
disruption of the bactericidal activity of PMNs. This is consistent
with the observation that the culture supernatant of RGP-null mutant
almost completely lost the inhibitory effect of the culture supernatant
of P. gingivalis on the CL response of PMNs (Fig. 5) (20).
In contrast, KDM35 showed a significant decrease in the
hemagglutinating activity, suggesting that KGP significantly
contributes to the generation of hemagglutinins from the initial
translation products of hemagglutinin-related genes, such as
rgp1, kgp, and hagA, B, C (49), in
P. gingivalis strains. However, because the RGP-null mutant
is almost devoid of the hemagglutinating activity, KGP seems likely to
make a relatively small contribution to the production of
hemagglutinins, as compared with RGP.
A noteworthy and unforeseen property of KDM35 was the reduced black
pigmentation. The characteristic black colonies of P. gingivalis on blood agar is thought to be caused by accumulation of heme. The ability to utilize heme and heme-containing compounds has
also been found in several pathogenic microorganisms (50). Black
pigmentation of colonies by heme accumulation, however, is known in
limited bacterial species in the genera Porphyromonas and
Prevotella. Although this property is thought to be related to virulence of P. gingivalis (51), it is not yet clear how P. gingivalis cells acquire heme from erythrocytes and other
host components. Recently, Fujimura et al. (34) isolated the
19-kDa hemoglobin-binding protein from the envelope of P. gingivalis by affinity chromatography. Then we found that the
19-kDa hemoglobin-binding protein was encoded by internal domain
regions (e.g. HGP15 in rgp1) of multiple genes:
rgp1, kgp, and hagA (32). We proposed renaming the hemoglobin-binding protein the hemoglobin receptor (HbR)
domain protein. In addition, we found that nonpigmented mutants (BE1
and BR1) isolated from P. gingivalis W50 did not express the
HbR domain protein and showed deficiency in hemoglobin adsorption,
which indicated a close relationship among HbR production, hemoglobin
adsorption, and pigmentation of P. gingivalis. P. gingivalis W50 BE1 also showed reduced virulence in mouse infection model, a
decrease in trypsin-like proteinase production, and loss of hemagglutination (45, 51). The HbR domain protein is likely to be
generated by proteolytic processing of the polyproteins from
rgp1, kgp, and hagA. The HbR protein
has a Lys residue at the carboxyl terminus, indicating involvement of
KGP in this cleavage. Immunoblot analysis with anti-HbR antiserum
revealed that KDM35 growing on the laked blood agar for 3 days had no
proteins immunoreacted with the antiserum, whereas the
kgp+ sibling strain KDM16 showed an
immunoreactive 19-kDa protein band. The results suggest the
contribution of KGP to the production of the HbR domain protein.
However, the HbR protein was produced in the cells of the KGP-deficient
mutant after prolonged incubation. This slow expression of the HbR
domain protein of KDM35 might account for its reduced pigmentation. Why
was the 19-kDa HbR domain protein detected in KDM35 after prolonged
incubation? It could be explained by the fact that the
carboxyl-terminal processing of the HbR domain protein in the KDM35
might be done in a much slower mode by an unknown proteinase. The
proteinase should not be specific for Lys-X, because the KGP-deficient
mutant showed no lysine-specific proteinase activity. Molecular mass of
the HbR protein expressed in the KGP-deficient mutant was almost the same as those of the wild-type strain and KDM16. Therefore, the cleavage site by the unknown proteinase should be very close to the
carboxyl-terminal Lys residue. Another possibility is that some of the
HbR domains in the rgp1 and hagA genes of strain
ATCC33277 may possess a different residue such as Arg at the carboxyl
terminus because the nucleotide sequences of these genes of the strain have not been determined. Furthermore, we cannot rule out the possibility of the presence of another anti-HbR cross-reactive protein
with a molecular mass of 19-kDa that might be expressed after prolonged
incubation on blood agar plates.
The final characterization of the KGP-deficient mutant KDM35 was the
association of KGP with the fibrinogenolytic activity. Fibrinogen is a
major component of the coagulation cascade. Upon cleavage by thrombin,
fibrin monomers polymerize and form a meshwork that traps platelets and
blood cells. Although the culture supernatants of the wild-type strain
and the RGP-null mutant extensively degraded all of the chains of
fibrinogen, that of the KGP-deficient mutant showed a marked decrease
in their degradation (especially the chain). It has been
demonstrated that the fibrinogen A chain is rapidly degraded by both
Arg-X- and Lys-X-specific cysteine proteinases from P. gingivalis and that Lys-X-specific cysteine proteinase(s) is a
much more potent fibrinogenolytic enzyme than Arg-specific cysteine
proteinase(s) (46-48). Our data in this report are also consistent
with these observations. The intense fibrinogenolytic activity of KGP
appears to render fibrinogen unclottable and may contribute to a
propensity for bleeding in periodontal pockets of periodontitis
patients. This may therefore represent another virulence that
facilitates the bacterial survival and invasion of host tissues.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
Research Fellow of the Japan Society for the Promotion of Science.
To whom all correspondence should be addressed. Tel.:
81-92-642-6339; Fax: 81-92-642-6342; E-mail:
kyama{at}dent.kyushu-u.ac.jp.
The abbreviations used are:
RGP, Arg-gingipain; CL, chemiluminescence; KGP, Lys-gingipain; MCA, 4-methyl-7-coumarl-amide; PBS, phosphate-buffered saline; PMN, polymorphonuclear leukocyte; kbp, kilobase pair(s); bp, base
pair.
2
T. Kadowaki, K. Nakayama, F. Yoshimura, K. Okamoto, and K. Yamamoto, submitted for publication.
 |
REFERENCES |
-
Yamamoto, K.,
Kadowaki, T.,
Okamoto, K.,
Abe, N.,
and Nakayama, K.
(1997)
in
Medical Aspects of Proteases and Protease Inhibitors (Katunuma, N., Kido, H., Fritz, H., and Travis, J., eds), pp. 139-149, IOS Press, Amsterdam
-
Travis, J.,
Pike, R.,
Imamura, T.,
and Potempa, J.
(1997)
J. Periodont. Res.
32,
120-125[CrossRef][Medline]
[Order article via Infotrieve]
-
Potempa, J.,
Pike, R.,
and Travis, J.
(1995)
Infect. Immun.
63,
1176-1182[Abstract]
-
Toda, K.,
Otsuka, M.,
Ishikawa, Y.,
Sato, M.,
Yamamoto, Y.,
and Nakamura, R.
(1984)
J. Periodont. Res.
19,
372-381[CrossRef][Medline]
[Order article via Infotrieve]
-
Lawson, D. A.,
and Meyer, T. F.
(1992)
Infect. Immun.
60,
1524-1529[Abstract/Free Full Text]
-
Sundqvist, G.,
Carlsson, S. G.,
and Hanstrom, L.
(1987)
J. Periodont. Res.
22,
300-306[CrossRef][Medline]
[Order article via Infotrieve]
-
Kadowaki, T.,
Yoneda, M.,
Okamoto, K.,
Maeda, K.,
and Yamamoto, K.
(1994)
J. Biol. Chem.
269,
21371-21378[Abstract/Free Full Text]
-
Sojar, H. T.,
Lee, J.-Y.,
Bedi, G. S.,
and Genco, R. J.
(1993)
Infect. Immun.
61,
2369-2376[Abstract/Free Full Text]
-
Bedi, G. S.,
and Williams, T.
(1994)
J. Biol. Chem.
269,
599-606[Abstract/Free Full Text]
-
Scott, C. F.,
Whitaker, E. J.,
Hammond, B. F.,
and Colman, R. W.
(1993)
J. Biol. Chem.
268,
7935-7942[Abstract/Free Full Text]
-
Birkedal-Hansen, H.,
Taylor, R. E.,
Zambon, J.,
Barwa, P. K.,
and Neiders, M. E.
(1988)
J. Periodont. Res.
23,
258-264[CrossRef][Medline]
[Order article via Infotrieve]
-
Uitto, V.-J.,
Larjava, H.,
Heino, J.,
and Sorsa, T.
(1989)
Infect. Immun.
57,
213-218[Abstract/Free Full Text]
-
Frandsen, E. V. G.,
Reinholdt, J. R.,
and Kilian, M.
(1987)
Infect. Immun.
55,
631-638[Abstract/Free Full Text]
-
Grenier, D.
(1992)
Infect. Immun.
60,
1854-1857[Abstract/Free Full Text]
-
Grenier, D.,
Mayrand, D.,
and McBride, B. C.
(1989)
Oral Microbiol. Immunol.
4,
12-18[Medline]
[Order article via Infotrieve]
-
Schenkein, H. A.
(1988)
J. Periodont. Res.
23,
187-192[CrossRef][Medline]
[Order article via Infotrieve]
-
Sundqvist, G. K.,
Carlsson, J.,
Hermann, B. F.,
Höfling, J. F.,
and Väätäinen, A.
(1984)
Scand. J. Dent. Res.
92,
14-24[Medline]
[Order article via Infotrieve]
-
Sundqvist, G. K.,
Bengtson, A.,
and Carlsson, J.
(1988)
Oral Microbiol. Immunol.
3,
103-107[Medline]
[Order article via Infotrieve]
-
Niekrash, C. E.,
and Patters, M. A.
(1986)
J. Periodont. Res.
21,
233-242[CrossRef][Medline]
[Order article via Infotrieve]
-
Nakayama, K.,
Kadowaki, T.,
Okamoto, K.,
and Yamamoto, K.
(1995)
J. Biol. Chem.
270,
23619-23626[Abstract/Free Full Text]
-
Nakayama, K.,
Yoshimura, F.,
Kadowaki, T.,
and Yamamoto, K.
(1996)
J. Bacteriol.
178,
2818-2824[Abstract/Free Full Text]
-
Hinode, D.,
Nagata, A.,
Ichimiya, S.,
Hayashi, H.,
Morioka, M.,
and Nakamura, R.
(1992)
Arch. Oral Biol.
37,
859-861[CrossRef][Medline]
[Order article via Infotrieve]
-
Imamura, T.,
Pike, R. N.,
Potempa, J.,
and Travis, J.
(1994)
J. Clin. Invest.
94,
361-367
-
Okamoto, K.,
Kadowaki, T.,
Nakayama, K.,
and Yamamoto, K.
(1996)
J. Biochem. (Tokyo)
120,
398-406[Abstract/Free Full Text]
-
Barkocy-Gallagher, G. A.,
Han, N.,
Patti, J. M.,
Whitlock, J.,
Progulski-Fox, A.,
and Lantz, M. S.
(1996)
J. Bacteriol.
178,
2734-2741[Abstract/Free Full Text]
-
Pavloff, N.,
Pemberton, P. A.,
Potempa, J.,
Chen, W.-C. A.,
Pike, R. N.,
Prochazka, V.,
Kiefer, M. C.,
Travis, J.,
and Barr, P. J.
(1997)
J. Biol. Chem.
272,
1595-1600[Abstract/Free Full Text]
-
Lippke, J. A.,
Strzempko, M. N.,
Raia, F. F.,
Simon, S. L.,
and Frech, C. K.
(1987)
Appl. Environ. Microbiol.
53,
2588-2589[Abstract/Free Full Text]
-
Nakayama, K.
(1997)
Microbiol. Immunol.
41,
185-196[Medline]
[Order article via Infotrieve]
-
Southern, E. M.
(1975)
J. Mol. Biol.
98,
503-517[CrossRef][Medline]
[Order article via Infotrieve]
-
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
-
Towbin, H.,
Staehelin, T.,
and Gordon, J.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4350-4354[Abstract/Free Full Text]
-
Nakayama, K.,
Ratnayake, D. B.,
Tsukuba, T.,
Kadowaki, T.,
Yamamoto, K.,
and Fujimura, S.
(1998)
Mol. Microbiol.
27,
51-61[CrossRef][Medline]
[Order article via Infotrieve]
-
Abe, N.,
Kadowaki-Tsukuba, T.,
Nakayama, K.,
Okamoto, K.,
Ohishi, M.,
and Yamamoto, K.
(1998)
J. Biochem. (Tokyo)
123,
305-312[Abstract/Free Full Text]
-
Fujimura, S.,
Shibata, Y.,
Hirai, K.,
and Nakamura, T.
(1996)
Infect. Immun.
64,
2339-2342[Abstract]
-
Lindegren, C. C.
(1955)
Science
121,
605-607[Free Full Text]
-
Orr-Weaver, T.,
Szostak, J. W.,
and Rothstein, R. J.
(1981)
Proc. Natl. Acad. Sci. U. S. A.
78,
6354-6358[Abstract/Free Full Text]
-
Yoneda, M.,
Maeda, K.,
and Aono, M.
(1990)
Infect. Immun.
58,
406-411[Abstract/Free Full Text]
-
Okamoto, K.,
Misumi, Y.,
Kadowaki, T.,
Yoneda, M.,
Yamamoto, K.,
and Ikehara, Y.
(1994)
Arch. Biochem. Biophys.
316,
917-925
-
Gibbons, R. J.,
and MacDonald, J. B.
(1960)
J. Bacteriol.
80,
164-170[Free Full Text]
-
Shah, H. N.,
Bonnett, R.,
Mateen, B.,
and Williams, R. A. D.
(1979)
Biochem. J.
180,
45-50[Medline]
[Order article via Infotrieve]
-
Chu, L.,
Bramanti, T. E.,
Ebersole, J. L.,
and Holt, S. C.
(1991)
Infect. Immun.
59,
1932-1940[Abstract/Free Full Text]
-
Shah, H. N.,
and Gharbia, S. E.
(1989)
FEMS Microbiol. Lett.
61,
213-218[CrossRef]
-
Pavloff, N.,
Potempa, J.,
Pike, R. N.,
Prochazka, V.,
Kiefer, M. C.,
Travis, J.,
and Barr, P. J.
(1995)
J. Biol. Chem.
270,
1007-1010[Abstract/Free Full Text]
-
Han, N.,
Whitlock, J.,
and Progulski-Fox, A.
(1996)
Infect. Immun.
64,
4000-4007[Abstract]
-
Mckee, A. S.,
McDermid, A. S.,
Wait, R.,
Baskerville, A.,
and Marsh, P. D.
(1988)
J. Med. Microbiol.
27,
59-64[Abstract/Free Full Text]
-
Scott, C. F.,
Whitaker, E. J.,
Hammond, B. F.,
and Colman, R. W.
(1993)
J. Biol. Chem.
268,
7935-7942
-
Ciborowski, P.,
Nishikata, M.,
Allen, R. D.,
and Lantz, M. S.
(1994)
J. Bacteriol.
176,
4549-4557[Abstract/Free Full Text]
-
Imamura, T.,
Potempa, J.,
Pike, R. N.,
Moore, J. N.,
Barton, M. H.,
and Travis, J.
(1995)
Infect. Immun.
63,
4877-4882[Abstract]
-
Lee, S.-W.,
Hillman, J. D.,
and Progulski-Fox, A.
(1996)
Infect. Immun.
64,
4802-4810[Abstract]
-
Genco, C. A.,
and Desai, P. J.
(1996)
Trends Microbiol.
4,
179-184[CrossRef][Medline]
[Order article via Infotrieve]
-
Shah, H. N.,
Seddon, S. V.,
and Gharbia, S. E.
(1989)
Oral Microbiol. Immunol.
4,
19-23[Medline]
[Order article via Infotrieve]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Sato, N. Kido, Y. Murakami, C. I. Hoover, K. Nakayama, and F. Yoshimura
Lipopolysaccharide biosynthesis-related genes are required for colony pigmentation of Porphyromonas gingivalis
Microbiology,
April 1, 2009;
155(4):
1282 - 1293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-A. Nguyen, J. Zylicz, P. Szczesny, A. Sroka, N. Hunter, and J. Potempa
Verification of a topology model of PorT as an integral outer-membrane protein in Porphyromonas gingivalis
Microbiology,
February 1, 2009;
155(2):
328 - 337.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Naito, H. Hirakawa, A. Yamashita, N. Ohara, M. Shoji, H. Yukitake, K. Nakayama, H. Toh, F. Yoshimura, S. Kuhara, et al.
Determination of the Genome Sequence of Porphyromonas gingivalis Strain ATCC 33277 and Genomic Comparison with Strain W83 Revealed Extensive Genome Rearrangements in P. gingivalis
DNA Res,
August 1, 2008;
15(4):
215 - 225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Yamatake, M. Maeda, T. Kadowaki, R. Takii, T. Tsukuba, T. Ueno, E. Kominami, S. Yokota, and K. Yamamoto
Role for Gingipains in Porphyromonas gingivalis Traffic to Phagolysosomes and Survival in Human Aortic Endothelial Cells
Infect. Immun.,
May 1, 2007;
75(5):
2090 - 2100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Pathirana, N. M. O'Brien-Simpson, G. C. Brammar, N. Slakeski, and E. C. Reynolds
Kgp and RgpB, but Not RgpA, Are Important for Porphyromonas gingivalis Virulence in the Murine Periodontitis Model
Infect. Immun.,
March 1, 2007;
75(3):
1436 - 1442.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Hashimoto, T. Kadowaki, T. Tsukuba, and K. Yamamoto
Selective Proteolysis of Apolipoprotein B-100 by Arg-Gingipain Mediates Atherosclerosis Progression Accelerated by Bacterial Exposure
J. Biochem.,
November 1, 2006;
140(5):
713 - 723.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Liu, T. Olczak, H.-C. Guo, D. W. Dixon, and C. A. Genco
Identification of Amino Acid Residues Involved in Heme Binding and Hemoprotein Utilization in the Porphyromonas gingivalis Heme Receptor HmuR
Infect. Immun.,
February 1, 2006;
74(2):
1222 - 1232.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. S. Soukos, S. Som, A. D. Abernethy, K. Ruggiero, J. Dunham, C. Lee, A. G. Doukas, and J. M. Goodson
Phototargeting Oral Black-Pigmented Bacteria
Antimicrob. Agents Chemother.,
April 1, 2005;
49(4):
1391 - 1396.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Sato, E. Sakai, P. D. Veith, M. Shoji, Y. Kikuchi, H. Yukitake, N. Ohara, M. Naito, K. Okamoto, E. C. Reynolds, et al.
Identification of a New Membrane-associated Protein That Influences Transport/Maturation of Gingipains and Adhesins of Porphyromonas gingivalis
J. Biol. Chem.,
March 11, 2005;
280(10):
8668 - 8677.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Takii, T. Kadowaki, A. Baba, T. Tsukuba, and K. Yamamoto
A Functional Virulence Complex Composed of Gingipains, Adhesins, and Lipopolysaccharide Shows High Affinity to Host Cells and Matrix Proteins and Escapes Recognition by Host Immune Systems
Infect. Immun.,
February 1, 2005;
73(2):
883 - 893.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kadowaki, A. Baba, N. Abe, R. Takii, M. Hashimoto, T. Tsukuba, S. Okazaki, Y. Suda, T. Asao, and K. Yamamoto
Suppression of Pathogenicity of Porphyromonas gingivalis by Newly Developed Gingipain Inhibitors
Mol. Pharmacol.,
December 1, 2004;
66(6):
1599 - 1606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Grenier, S. Roy, F. Chandad, P. Plamondon, M. Yoshioka, K. Nakayama, and D. Mayrand
Effect of Inactivation of the Arg- and/or Lys-Gingipain Gene on Selected Virulence and Physiological Properties of Porphyromonas gingivalis
Infect. Immun.,
August 1, 2003;
71(8):
4742 - 4748.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Olango, F. Roy, S. M. Sheets, M. K. Young, and H. M. Fletcher
Gingipain RgpB Is Excreted as a Proenzyme in the vimA-Defective Mutant Porphyromonas gingivalis FLL92
Infect. Immun.,
July 1, 2003;
71(7):
3740 - 3747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Paramaesvaran, K.-A. Nguyen, E. Caldon, J. A. McDonald, S. Najdi, G. Gonzaga, D. B. Langley, A. DeCarlo, M. J. Crossley, N. Hunter, et al.
Porphyrin-Mediated Cell Surface Heme Capture from Hemoglobin by Porphyromonas gingivalis
J. Bacteriol.,
April 15, 2003;
185(8):
2528 - 2537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. DeCarlo, Y. Huang, C. A. Collyer, D. B. Langley, and J. Katz
Feasibility of an HA2 Domain-Based Periodontitis Vaccine
Infect. Immun.,
January 1, 2003;
71(1):
562 - 566.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Curtis, J. Aduse Opoku, M. Rangarajan, A. Gallagher, J. A. C. Sterne, C. R. Reid, H. E. A. Evans, and B. Samuelsson
Attenuation of the Virulence of Porphyromonas gingivalis by Using a Specific Synthetic Kgp Protease Inhibitor
Infect. Immun.,
December 1, 2002;
70(12):
6968 - 6975.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bosch, M. E. Garrido, M. Llagostera, A. M. Perez de Rozas, I. Badiola, and J. Barbe
Characterization of the Pasteurella multocida hgbA Gene Encoding a Hemoglobin-Binding Protein
Infect. Immun.,
November 1, 2002;
70(11):
5955 - 5964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. S. Rajapakse, N. M. O'Brien-Simpson, N. Slakeski, B. Hoffmann, and E. C. Reynolds
Immunization with the RgpA-Kgp Proteinase-Adhesin Complexes of Porphyromonas gingivalis Protects against Periodontal Bone Loss in the Rat Periodontitis Model
Infect. Immun.,
May 1, 2002;
70(5):
2480 - 2486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shoji, D. B. Ratnayake, Y. Shi, T. Kadowaki, K. Yamamoto, F. Yoshimura, A. Akamine, M. A. Curtis, and K. Nakayama
Construction and characterization of a nonpigmented mutant of Porphyromonas gingivalis: cell surface polysaccharide as an anchorage for gingipains
Microbiology,
April 1, 2002;
148(4):
1183 - 1191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. O'Brien-Simpson, R. A. Paolini, B. Hoffmann, N. Slakeski, S. G. Dashper, and E. C. Reynolds
Role of RgpA, RgpB, and Kgp Proteinases in Virulence of Porphyromonas gingivalis W50 in a Murine Lesion Model
Infect. Immun.,
December 1, 2001;
69(12):
7527 - 7534.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. C. Gibson III and C. A. Genco
Prevention of Porphyromonas gingivalis-Induced Oral Bone Loss following Immunization with Gingipain R1
Infect. Immun.,
December 1, 2001;
69(12):
7959 - 7963.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Olczak, D. W. Dixon, and C. A. Genco
Binding Specificity of the Porphyromonas gingivalis Heme and Hemoglobin Receptor HmuR, Gingipain K, and Gingipain R1 for Heme, Porphyrins, and Metalloporphyrins
J. Bacteriol.,
October 1, 2001;
183(19):
5599 - 5608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sroka, M. Sztukowska, J. Potempa, J. Travis, and C. A. Genco
Degradation of Host Heme Proteins by Lysine- and Arginine-Specific Cysteine Proteinases (Gingipains) of Porphyromonas gingivalis
J. Bacteriol.,
October 1, 2001;
183(19):
5609 - 5616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Nisapakultorn, K. F. Ross, and M. C. Herzberg
Calprotectin Expression In Vitro by Oral Epithelial Cells Confers Resistance to Infection by Porphyromonas gingivalis
Infect. Immun.,
July 1, 2001;
69(7):
4242 - 4247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kuboniwa, A. Amano, S. Shizukuishi, I. Nakagawa, and S. Hamada
Specific Antibodies to Porphyromonas gingivalis Lys-Gingipain by DNA Vaccination Inhibit Bacterial Binding to Hemoglobin and Protect Mice from Infection
Infect. Immun.,
May 1, 2001;
69(5):
2972 - 2979.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Abaibou, Z. Chen, G. J. Olango, Y. Liu, J. Edwards, and H. M. Fletcher
vimA Gene Downstream of recA Is Involved in Virulence Modulation in Porphyromonas gingivalis W83
Infect. Immun.,
January 1, 2001;
69(1):
325 - 335.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.A. Curtis, J. Aduse-Opoku, and M. Rangarajan
Cysteine Proteases of Porphyromonas Gingivalis
Critical Reviews in Oral Biology & Medicine,
January 1, 2001;
12(3):
192 - 216.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Simpson, T. Olczak, and C. A. Genco
Characterization and Expression of HmuR, a TonB-Dependent Hemoglobin Receptor of Porphyromonas gingivalis
J. Bacteriol.,
October 15, 2000;
182(20):
5737 - 5748.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Aduse-Opoku, N. N. Davies, A. Gallagher, A. Hashim, H. E. A. Evans, M. Rangarajan, J. M. Slaney, and M. A. Curtis
Generation of Lys-gingipain protease activity in Porphyromonas gingivalis W50 is independent of Arg-gingipain protease activities
Microbiology,
August 1, 2000;
146(8):
1933 - 1940.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
T. Chen, H. Dong, Y. P. Tang, M. M. Dallas, M. H. Malamy, and M. J. Duncan
Identification and Cloning of Genes from Porphyromonas gingivalis after Mutagenesis with a Modified Tn4400 Transposon from Bacteroides fragilis
Infect. Immun.,
January 1, 2000;
68(1):
420 - 423.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Abiko
Passive Immunization Against Dental Caries and Periodontal Disease: Development of Recombinant and Human Monoclonal Antibodies
Critical Reviews in Oral Biology & Medicine,
January 1, 2000;
11(2):
140 - 158.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Simpson, C.-Y. Wang, J. Mikolajczyk-Pawlinska, J. Potempa, J. Travis, V. C. Bond, and C. A. Genco
Transposition of the Endogenous Insertion Sequence Element IS1126 Modulates Gingipain Expression in Porphyromonas gingivalis
Infect. Immun.,
October 1, 1999;
67(10):
5012 - 5020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Chen and H. K. Kuramitsu
Molecular Mechanism for the Spontaneous Generation of Pigmentless Porphyromonas gingivalis Mutants
Infect. Immun.,
September 1, 1999;
67(9):
4926 - 4930.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Lewis, J. A. Dawson, J. C. Hannis, D. Muddiman, and F. L. Macrina
Hemoglobinase Activity of the Lysine Gingipain Protease (Kgp) of Porphyromonas gingivalis W83
J. Bacteriol.,
August 15, 1999;
181(16):
4905 - 4913.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. C. Lynch and H. K. Kuramitsu
Role of Superoxide Dismutase Activity in the Physiology of Porphyromonas gingivalis
Infect. Immun.,
July 1, 1999;
67(7):
3367 - 3375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Shi, D. B. Ratnayake, K. Okamoto, N. Abe, K. Yamamoto, and K. Nakayama
Genetic Analyses of Proteolysis, Hemoglobin Binding, and Hemagglutination of Porphyromonas gingivalis. CONSTRUCTION OF MUTANTS WITH A COMBINATION OF rgpA, rgpB, kgp, AND hagA
J. Biol. Chem.,
June 18, 1999;
274(25):
17955 - 17960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. A. DeCarlo, M. Paramaesvaran, P. L. W. Yun, C. Collyer, and N. Hunter
Porphyrin-Mediated Binding to Hemoglobin by the HA2 Domain of Cysteine Proteinases (Gingipains) and Hemagglutinins from the Periodontal Pathogen Porphyromonas gingivalis
J. Bacteriol.,
June 15, 1999;
181(12):
3784 - 3791.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Y. Shibata, M. Hayakawa, H. Takiguchi, T. Shiroza, and Y. Abiko
Determination and Characterization of the Hemagglutinin-associated Short Motifs Found in Porphyromonas gingivalis Multiple Gene Products
J. Biol. Chem.,
February 19, 1999;
274(8):
5012 - 5020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kadowaki, K. Nakayama, F. Yoshimura, K. Okamoto, N. Abe, and K. Yamamoto
Arg-gingipain Acts as a Major Processing Enzyme for Various Cell Surface Proteins in Porphyromonas gingivalis
J. Biol. Chem.,
October 30, 1998;
273(44):
29072 - 29076.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|